Cargando…

Imaging Features of Hepatocellular Carcinoma in the Non-Cirrhotic Liver with Sonazoid-Enhanced Contrast-Enhanced Ultrasound

Purpose: To investigate the Sonazoid-enhanced contrast-enhanced ultrasound (CEUS) features of hepatocellular carcinoma (HCC) in a non-cirrhosis liver background, in comparison to those in liver cirrhosis. Methods: In this retrospective study, 19 patients with surgery and histopathologically proven H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Sheng, Qiu, Yi-Jie, Zuo, Dan, Shi, Shuai-Nan, Wang, Wen-Ping, Dong, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601233/ https://www.ncbi.nlm.nih.gov/pubmed/36291962 http://dx.doi.org/10.3390/diagnostics12102272

Ejemplares similares

Prediction of Histological Grades and Ki-67 Expression of Hepatocellular Carcinoma Based on Sonazoid Contrast Enhanced Ultrasound Radiomics Signatures
por: Dong, Yi, et al.
Publicado: (2022)

Use of Contrast-Enhanced Ultrasound with Sonazoid for Evaluating the Radiotherapy Efficacy for Hepatocellular Carcinoma
por: Funaoka, Akihiro, et al.
Publicado: (2021)

Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma: strengths and shortcomings
por: Lee, Sung Won, et al.
Publicado: (2023)

The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid
por: Lee, Jae Young, et al.
Publicado: (2020)

The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid
por: Lee, Jae Young, et al.
Publicado: (2020)

Prediction of the Ki-67 marker index in hepatocellular carcinoma based on Dynamic Contrast-Enhanced Ultrasonography with Sonazoid
por: Huang, Zhe, et al.
Publicado: (2022)

Findings of contrast-enhanced ultrasonography with Sonazoid for cholangiocellular adenoma in three dogs
por: TAMURA, Masahiro, et al.
Publicado: (2019)

Ultrasound contrast agent Sonazoid for the diagnosis of hepatic epithelioid angiomyolipoma: a case report
por: Huang, Zhe, et al.
Publicado: (2021)

Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancer
por: Mishima, Mai, et al.
Publicado: (2014)

Evaluation of Hemodynamics in Focal Steatosis and Focal Spared Lesion of the Liver Using Contrast-Enhanced Ultrasonography with Sonazoid
por: Shiozawa, Kazue, et al.
Publicado: (2014)

Kupffer Phase Radiomics Signature in Sonazoid-Enhanced Ultrasound is an Independent and Effective Predictor of the Pathologic Grade of Hepatocellular Carcinoma
por: Li, Chen, et al.
Publicado: (2022)

The Efficacy of Sonazoid-enhanced Ultrasonography in Decision-making for Liver Abscess Treatment
por: Morita, Masahiro, et al.
Publicado: (2020)

Noninvasive Diagnosis of Hepatocellular Carcinoma on Sonazoid-Enhanced US: Value of the Kupffer Phase
por: Takahashi, Hiroshi, et al.
Publicado: (2022)

Prospective assessment of diagnostic efficacy and safety of Sonazoid(TM) and SonoVue(®) ultrasound contrast agents in patients with focal liver lesions
por: Lv, Ke, et al.
Publicado: (2021)

Sonazoid™ versus SonoVue(®) for Diagnosing Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound in At-Risk Individuals: A Prospective, Single-Center, Intraindividual, Noninferiority Study
por: Kang, Hyo-Jin, et al.
Publicado: (2022)

A novel method to determine hepatic segments using Sonazoid, an ultrasound contrast agent
por: Ham, Taehyuk, et al.
Publicado: (2020)

Contrast-enhanced ultrasound features of hepatocellular carcinoma in dogs
por: Banzato, Tommaso, et al.
Publicado: (2020)

Sonazoid-enhanced ultrasonography: comparison with CT/MRI Liver Imaging Reporting and Data System in patients with suspected hepatocellular carcinoma
por: Hwang, Jeong Ah, et al.
Publicado: (2021)

Safety of Perfluorobutane (Sonazoid) in Characterizing Focal Liver Lesions
por: Chou, Yi-Hong, et al.
Publicado: (2019)

Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology
por: Jeong, Woo Kyoung, et al.
Publicado: (2023)

Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography
por: Li, Rui, et al.
Publicado: (2016)

Diagnosis of Hepatic Angiomyolipoma by Combination of Baseline and Contrast-Enhanced Ultrasound—A Prospective Study in Non-Cirrhotic Patients
por: Li, Rui, et al.
Publicado: (2015)

Role of Sonazoid enhanced ultrasound assistant laparoscopic radiofrequency ablation in treating liver malignancy—A single‐center retrospective cohort study
por: Xu, Jingyong, et al.
Publicado: (2023)

Sonazoid-enhanced ultrasonography for noninvasive imaging diagnosis of hepatocellular carcinoma: special emphasis on the 2022 KLCA-NCC guideline
por: Kang, Hyo-Jin, et al.
Publicado: (2023)

Early Assessment of Chemoradiotherapy Response for Locally Advanced Pancreatic Ductal Adenocarcinoma by Dynamic Contrast-Enhanced Ultrasound
por: Lu, Xiu-Yun, et al.
Publicado: (2022)

Diagnosis of hepatocellular carcinoma using Sonazoid: a comprehensive review
por: Jeong, Woo Kyoung
Publicado: (2023)

Clinical significance of performing Sonazoid-based contrast-enhanced ultrasonography before ablation of uterine fibroids by high-intensity focused ultrasound: A preliminary cohort study
por: Zhang, Lu, et al.
Publicado: (2021)

Potential value of sonazoid-enhanced intraoperative laparoscopic ultrasonography for liver assessment during laparoscopy-assisted colectomy
por: Itabashi, Tetsuya, et al.
Publicado: (2013)

Identification of sentinel lymph nodes by contrast‐enhanced ultrasonography with Sonazoid in patients with breast cancer: a feasibility study in three hospitals
por: Shimazu, Kenzo, et al.
Publicado: (2017)

Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial
por: Park, Ji Hoon, et al.
Publicado: (2017)

Contrast-enhanced ultrasound features of malignant focal liver masses in dogs
por: Burti, Silvia, et al.
Publicado: (2020)

Modified CEUS LI-RADS using Sonazoid for the diagnosis of hepatocellular carcinoma
por: Sugimoto, Katsutoshi, et al.
Publicado: (2023)

Contrast-Enhanced Imaging Features and Clinicopathological Investigation of Steatohepatitic Hepatocellular Carcinoma
por: Chen, Kailing, et al.
Publicado: (2023)

Upper gastrointestinal tract perforation assessed by contrast-enhanced ultrasonography after oral Sonazoid administration in a stomach leakage mouse model
por: Jung, Kyuhwan, et al.
Publicado: (2023)

Characterization of Focal Liver Lesions Indistinctive on B Mode Ultrasound: Benefits of Contrast-Enhanced Ultrasound
por: Dong, Yi, et al.
Publicado: (2017)

Contrast enhanced delayed myocardial enhancement in patients with end stage liver cirrhosis – further evidence for cirrhotic cardiomyopathy
por: Lossnitzer, Dirk, et al.
Publicado: (2009)

Second-line Sonazoid-enhanced ultrasonography for Liver Imaging Reporting and Data System category 3 and 4 on gadoxetate-enhanced magnetic resonance imaging
por: Kim, Yeun-Yoon, et al.
Publicado: (2022)

Usefulness of Modified CEUS LI-RADS for the Diagnosis of Hepatocellular Carcinoma Using Sonazoid
por: Sugimoto, Katsutoshi, et al.
Publicado: (2020)

Accurate evaluation of axillary sentinel lymph node metastasis using contrast-enhanced ultrasonography with Sonazoid in breast cancer: a preliminary clinical trial
por: Matsuzawa, Fumihiko, et al.
Publicado: (2015)

Grey scale enhancement by a new self-made contrast agent in early cirrhotic stage of rabbit liver
por: Zhang, Li, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_im067fm01qhkhtf84o7tt3a2p8